ONDINE BIOMEDICAL INC COM SHS NPV (CDI) revenue breakdown overview

ONDINE BIOMEDICAL INC COM SHS NPV (CDI) revenue for the last year amounted to 1.56 M GBP, the most of which — 717.04 k GBP — came from its highest performing source at the moment, Antimicrobial Photodynamic Therapy, the year earlier bringing 397.86 k GBP. The greatest contribution to the revenue figure was made by Canada — last year it brought ONDINE BIOMEDICAL INC COM SHS NPV (CDI) 669.95 k GBP, and the year before that — 371.66 k GBP.